康恩贝：全资子公司取得药品注册证书

Group 1 - The core point of the article is that Kang En Bei Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for its 0.25g tranexamic acid tablets [2] - Kang En Bei's revenue composition for the year 2024 is as follows: manufacturing (pharmaceutical industry) accounts for 86.86%, commercial sales for 11.77%, and other businesses for 1.37% [2]